Nevan Krogan, PhD
Protein-Protein Interactions Co-Lead
Nevan Krogan, PhD, is a molecular biologist and professor at the University of California, San Francisco, where he is also the Director of the Quantitative Biosciences Institute (QBI) under the UCSF School of Pharmacy. He is also a senior investigator at the Gladstone Institutes.
He led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG), which includes hundreds of scientists from around the world. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics.
Nevan serves as Director of The HARC Center, an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Nevan is also the co-Director of four Cell Mapping initiatives: the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI), the Psychiatric Cell Map Initiative (PCMI), and the (QCRG AViDD) NIH grant, which is the largest research grant awarded in the University of California history. These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them.
Nevan has authored over 400 papers in the fields of genetics and molecular biology and has given over 400 lectures and seminars around the world. He is a Searle Scholar, a Keck Distinguished Scholar, a recipient of the Roddenberry Prize for Biomedical Research, and was recently elected to EMBO (European Molecular Biology Organization) membership. In recognition of his collaborative work bringing scientists across the globe to work together on SARS-CoV-2, Nevan Krogan was awarded the French Legion of Honor in 2021, the Louis Pasteur Medal in 2022, and the Research!America Discovery|Innovation|Health Prize in 2023. In 2024, Nevan was named to the Cell Press 50 Scientists that Inspire. In 2025, Nevan was awarded an Einstein Foundation Visiting Fellowship.